Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of Robert E. Landry to its Board of Directors. Mr. Landry brings over three decades of financial and operational expertise in ...

Chili's® Grill & Bar is shifting into high gear for the 2025 NASCAR season with the launch of its new 'Ride the Dente'tm campaign. The campaign is part of a multi-race partnership extension with Spire ...

On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...

Regeneron is also embroiled in a securities fraud class action lawsuit stemming from a significant stock price drop on October 31, 2024. Shares plunged $84.59 that day, wiping out approximately $9 ...

Regeneron has won a court ruling that will make it harder for U.S. authorities to win a lawsuit accusing it of paying illegal ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days. Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and ...

This was the stock's second consecutive day of losses.

Regeneron and Sanofi said an FDA green light would make Dupixent the first targeted medicine in the U.S. for bullous pemphigoid, a debilitating and relapsing skin disease with underlying type 2 ...

Regeneron bought the global rights to the cancer drug from partner Sanofi in 2022. The company reported an adjusted profit of $12.07 per share in the quarter, above analysts' average estimate of ...

Meghan Markle's As Ever logo includes a tribute to Prince Harry. Inside the symbolism and what the Duchess of Sussex has said ...